Reference 12

Level I Good quality evidence Systematic review of RCTs with
consistent findings
High quality individual RCT
Level II Limited quality patient
orientated evidence
Systematic review of lower quality
studies or studies with inconsistent
findings
Low quality clinical trial
Cohort studies
Case-control studies
Level III Other Consensus guidelines, extrapolations
from bench research, usual practice,
opinion, disease-oriented evidence
(intermediate or physiologic outcomes
only), or case series

[12] Proton pump inhibitor (therapeutic class): National Department of Health: Affordable Medicines, EDP-Adult Hospital level. Medicine Review: Proton pump inhibitor therapeutic class review, May 2018. http://www.health.gov.za

Proton pump inhibitor (therapeutic class): McDonagh MS, Carson S, Thakurta S. Drug Class Review: Proton Pump Inhibitors: Final Report Update 5 [Internet]. Portland (OR): Oregon Health & Science University; 2009 May. http://www.ncbi.nlm.nih.gov/books/NBK47260/

Proton pump inhibitor (therapeutic class): National Institute for Health and Care Excellence: Clinical Guidelines: Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. https://www.nice.org.uk/guidance/cg184

Proton pump inhibitor: Contract circular HP09-2014SD. http://www.health.gov.za

Proton pump inhibitor (high risk patients on chronic NSAID therapy): McQuaid KR , Laine L . Systemic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med 2006;119:624–38. http://www.ncbi.nlm.nih.gov/pubmed/16887404

Proton pump inhibitor (high risk patients on chronic NSAID therapy): Serrano P, Lanas A, Arroyo MT, Ferreira IJ. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther. 2002 Nov;16(11):1945-53. http://www.ncbi.nlm.nih.gov/pubmed/12390104

Proton pump inhibitor (high risk patients on chronic NSAID therapy): Lanza FL, Chan FK, Quigley EM; Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009 Mar;104(3):728-38. http://www.ncbi.nlm.nih.gov/pubmed/19240698